Maryland Caps Ozempic at $274, Saving State $5.8M Yearly
Maryland just became one of the first states to cap the price of a blockbuster diabetes drug, potentially saving millions while making lifesaving medication more affordable. The move could spark a nationwide shift in how states tackle soaring prescription costs.